Immunotherapy uses a person's own immune system to fight cancer. Immune checkpoint inhibitors are one class of immunotherapy ...

Amy Rainbow, mum to seven-year-old Elliot and four-year-old Harper, is being treated for life-limiting brain tumours. She has already outlived the three months doctors gave her 18 months ago and now ...

Pancreatic cancer remains one of the most formidable oncological challenges of our time. Known for its late detection and ...

Sancho’s work highlights a key limitation in the current field of cancer treatment: dendritic cells can often be overlooked when developing immunotherapies. Overall, this work could improve long-term ...

An expert discusses how treatment selection in blastic plasmacytoid dendritic cell neoplasm (BPDCN) involves balancing ...

Analysts anticipate Lineage Cell Therapeutics to report an earnings per share (EPS) of $-0.03. Anticipation surrounds Lineage ...

What if we could reprogramme the TME itself? Cutting-edge research suggests that engineered mesenchymal stem cells (MSCs) ...

Phase 1 investigator-initiated study of Plinabulin + PD-1/PD-L1 inhibitor + radiation (MD Anderson Cancer Center) showed ...

First-line treatment with a Keytruda combo had an overall survival of 17.6 months in some with recurrent/metastatic head and ...